 SALT LAKE CITY, Jan. 04, 2021 GLOBE NEWSWIRE -- Paul J. Diaz, president and CEO of Myriad Genetics, Inc. NASDAQ: MYGN, a leader in precision medicine and molecular diagnostics, will discuss the companys transformation and growth initiatives at the 39th Annual J.P. Morgan Healthcare Conference at 2:50 p.m. EST on January 11, 2021. 